Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
Crossref DOI link: https://doi.org/10.1136/jnnp-2013-306936
Published Online: 2014-02-14
Published Print: 2014-11-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Butzkueven, H.
Kappos, L.
Pellegrini, F.
Trojano, M.
Wiendl, H.
Patel, R. N.
Zhang, A.
Hotermans, C.
Belachew, S.
,